Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Committee calls for GM insects
Grasshopper
The technology is believed to have the potential to help control diseases such as dengue and malaria.

Technology may have potential to help control diseases and pests

The House of Lords are calling on the Government to launch a field trial of genetically modified (GM) insects and make the most of the UK's status as a world leader in this area.

The technology is believed to have the potential to help control diseases such as dengue and malaria, by rendering insects unable to transmit disease.  This could potentially help almost half of the global population, who live in at-risk areas.

It is thought that GM technology could also reduce insect populations to minimise their threat to animals and crops, saving the world billions of pounds in the process.  

The call follows the publication of a report by the House of Lords Science and Technology Committee into Genetically Modified insects. In it, they state that GM insects have considerable potential to control insect-borne disease and agricultural pests, but they are no 'silver bullet'.

The report describes how the UK, a world leader in this area of research, could reap significant economic benefits. However, it says that EU regulation is 'failing lamentably'.

Commenting on the report, the Earl of Selborne, chairman of the House of Lords Science and Technology Committee, explains:

"GM insect technologies have the potential not only to save countless lives worldwide, but also to generate significant economic benefits for UK plc, where we are an acknowledged world leader. But the development of GM insect technologies has come to a screeching halt because the EU regulatory system is woefully inadequate. Until we can get a regulatory framework that will do justice to this area of scientific research, its wings are effectively clipped.

"Our report concludes that the UK Government has a moral duty to test the potential of this technology, for the long-term benefit of those countries where diseases like dengue and malaria are indiscriminate killers. So as a first step towards that goal, we urge the Government to initiate field trials to put not only the science but, crucially, the regulations to the test. This trial could also be a focus to increase public engagement in the area."

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.